Form D — Immunomet Therapeutics, Inc.
0002109829-26-000001 · filed 2026-02-05
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $10,000,000
- Total sold
- $842,211
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Immunomet Therapeutics, Inc.
- CIK
- 2109829
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2450 HOLCOMBE BLVD.
HOUSTON, TX 77021 - Phone
- 346-772-0318
Related persons
-
Dean Welsch · Executive OfficerHouston, TX
View original on SEC EDGAR.